ArticleBrain : a journal of neurology2018

Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept.

Izumi Maezawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.